Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001178913-23-003439
Filing Date
2023-10-30
Accepted
2023-10-30 08:33:35
Documents
3

Document Format Files

Seq Description Document Type Size
1 F-3/A zk2330437.htm F-3/A 719777
2 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 2938
3 image0.jpg GRAPHIC 74194
  Complete submission text file 0001178913-23-003439.txt   826027
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | Fiscal Year End: 1231
Type: F-3/A | Act: 33 | File No.: 333-275002 | Film No.: 231357522
SIC: 2834 Pharmaceutical Preparations